[Pyr1]-Apelin-13 (Human, Bovine)

[Pyr1]-Apelin-13 (Human, Bovine)

0.5 mg
€85,00

Sie können eine Angebotsanfrage erstellen, nachdem Sie das Produkt in den Warenkorb gelegt haben.

Zu Produktinformationen springen
[Pyr1]-Apelin-13 (Human, Bovine)
  • [Pyr1]-Apelin-13 (Human, Bovine)
  • [Pyr1]-Apelin-13 (Human, Bovine)

[Pyr1]-Apelin-13 (Human, Bovine)

Produkt-ID: 4361

Pyr-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe

€85,00
exkl. 19% MwSt.
Beschreibung

M.W. 1533.8

C69H108N22O16S

217082-60-5

Pyr-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe

Ligand for APJ ReceptorApelin has been described as endogenous ligand for human APJ. Its pyroglutaminated C-terminal peptide [Pyr1]-Apelin-13 ( [pGlu]-Apelin-13 ) was more potent than Apelin-36 in competitive inhibition assays. This pyroglutaminated peptide shows in vivo very high vascular effects. [Pyr1]-Apelin-13 shows a clear vasodilation effect in man.

Synthetic Product

The purity is guaranteed to be higher than 99% by HPLC

Referenzen:

1. K. Tatemoto, M. Hosoya, Y. Habata, R. Fujii, T. Takegawa, M.-X. Zou, Y. Kawamata, S. Fukusumi, S. Hinuma, C. Kitada, T. Kurokawa, H. Onda and M. Fujino, Biochem. Biophys. Res. Commun., 251, 471 (1998) (Original; Human and Bovine) 2. M.X. Zou, H.Y. Liu, Y. Haraguchi, Y. Soda, K. Tatemoto and H. Hoshido, FEBS Lett., 473, 15 (2000) (Pharmacol.) 3. M. Hosoya, Y. Kawamata, S. Fukusumi, R. Fujii, Y. Habata, S. Hinuma, C. Kitada, S. Honda, T. Kurukawa, H. Onda, O. Nishimura and M. Fujino, J. Biol. Chem., 275, 21061 (2000) (Pharmacol.)

The synthetic peptide [Pyr1]-Apelin-13 is distributed through Peptide Institute, Inc. under the license of Takeda Pharmaceutical Company , Ltd.

You may also like